Impact of Intrathecal Therapy on Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Compared to a Historical Cohort: A Single Center AnalysisGrace Mercadante, Shakthi Bhaskar, Phavina A Akhom et al.|Transplantation and Cellular Therapy|2026Cited by 0
Thiotepa-Based Conditioning Regimens for Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell TransplantJarrod T. Smith, Andrew Jallouk, Vivek Patel et al.|Transplantation and Cellular Therapy|2026Cited by 0
Outpatient Chimeric Antigen Receptor T cell Therapy in Patients Who Resided at Their Home Compared to Hospital-Provided Housing: A Single Institution ExperienceEmmanuella Iyore Osamuyi, Eden Biltibo, Nur Ali et al.|Transplantation and Cellular Therapy|2026Cited by 0
Feasibility of Outpatient Administration of Ciltacabtagene Autoleucel for the Treatment of Relapsed Refractory Multiple Myeloma: The Vanderbilt ExperienceMegan Wanca, Eden Biltibo, Grace Johnson Mercadante et al.|Transplantation and Cellular Therapy|2026Cited by 0